Corrigendum to "Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years' Follow-up of DEFINE, CONFIRM, and ENDORSE"
- PMID: 35173806
- PMCID: PMC8842109
- DOI: 10.1177/1756286420968357
Corrigendum to "Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years' Follow-up of DEFINE, CONFIRM, and ENDORSE"
Abstract
[This corrects the article DOI: 10.1177/1756286420915005.].
© The Author(s), 2020.
Figures
Erratum for
-
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE.Ther Adv Neurol Disord. 2020 May 12;13:1756286420915005. doi: 10.1177/1756286420915005. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32426039 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
